Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We’re delighted to announce that the Director of the Oxford BHF Centre of Research Excellence, Prof Hugh Watkins, has been elected a Fellow of the Royal Society. This is a very prestigious honour and one that recognises Hugh’s pioneering heart disease work and commitment to scientific research.

Hugh Watkins is a physician scientist whose work has helped reveal the genetic basis of inherited heart diseases and has led to new approaches to diagnosis and therapy with substantial benefit to patients. 

His work on hypertrophic cardiomyopathy showed that this common, life-threatening, heart muscle disorder is caused by mutations in the molecular motor proteins of the heart. These findings highlighted novel aspects of muscle physiology and cardiac energetics, opening the way to new approaches to therapy. He went on to develop direct genetic testing and show its clinical utility for identifying individuals at risk; adoption of genetic testing has transformed clinical care for affected families worldwide. 

The Fellowship of the Royal Society is made up of the most eminent scientists, engineers and technologists from or living and working in the UK and the Commonwealth. Hugh joins an impressive roster of researchers past and present.

Congratulations to Hugh on this well-deserved achievement. 

You can read more about this year’s elected Fellows on the Royal Society website.

Similar stories

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.

Study indicates reasons for decline in death rates from heart attacks

A new study involving Oxford Population Health researchers finds that both prevention and improved treatments have helped reduce deaths from heart attacks - but the relative importance of each varies by country, age and sex.

Review highlights impact of Long COVID on cardiovascular system

The wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID on the cardiovascular system.

Commercial development of therapeutic anti-inflammatory peptide begins

An Oxford BHF CRE “Pump Priming” award to Professor Shoumo Bhattacharya and his research group led to a great return on investment with this exclusive licensing agreement for their innovative research.

London Marathon to fund De Val and Vieira Lab research as two of eight handpicked BHF projects

Two projects aimed at tackling heart failure led by Associate Professor Sarah De Val and Dr Joaquim Vieira are to be funded by the 2022 TCS London Marathon with the British Heart Foundation as its Charity of the Year. The BHF’s runners, who are raising £3 million in funding, will include De Val Lab postdoctoral researcher Dr Alice Neal.

Dr Qiang Zhang wins Society for Cardiovascular Magnetic Resonance Early Career Award 2022

Many congratulations to Dr Qiang Zhang, Oxford BHF CRE Transition Fellow, who has won a prestigious award for his work in developing a groundbreaking technology for detecting scar in the myocardium